Sectors
PCVX
Vaxcyte, Inc.
60.74
2 x 43.47
2 x 76.49
bid
ask
+
0.91
1.51%
2 @ 05:07 PM
60.74 +0.00 (0.00%)
| Ytd | 31.64% | |
| 1y | 97.27% |
58.51
day range
61.61
30.81
52 week range
65.00
| Open | 59.10 | Prev Close | 59.84 | Low | 58.51 | High | 61.61 | Mkt Cap | 9.04B |
| Vol | 1.52M | Avg Vol | 1.31M | EPS | -7.63 | P/E | N/A | Forward P/E | -8.42 |
| Beta | 1.21 | Short Ratio | 15.42 | Inst. Own | 113.45% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-03 | 50-d Avg | 57.34 | 200-d Avg | 53.71 | 1yr Est | 109.00 |
| Income Statement | |||
| Operating Expenses | 302.78M | ||
| Research and Development Expense | 267.85M | ||
| Selling, General and Administrative Expense | 34.92M | ||
| Operating Income | -302.78M | ||
| Net Income | -284.30M | ||
| Net Income Common Stock | -284.30M | ||
| Net Income Common Stock (USD) | -284.30M | ||
| Consolidated Income | -284.30M | ||
| Earnings per Basic Share | -1.97 | ||
| Earnings per Basic Share (USD) | -1.97 | ||
| Earnings per Diluted Share | -1.97 | ||
| Earning Before Interest & Taxes (EBIT) | -284.30M | ||
| Earning Before Interest & Taxes (USD) | -284.30M | ||
| Weighted Average Shares | 144.49M | ||
| Weighted Average Shares Diluted | 144.49M | ||
| Balance Sheet | |||
| Cash and Equivalents | 183.19M | ||
| Cash and Equivalents (USD) | 183.19M | ||
| Investments | 2.33B | ||
| Investments Current | 1.30B | ||
| Investments Non-Current | 1.02B | ||
| Current Assets | 1.55B | ||
| Property, Plant & Equipment Net | 370.57M | ||
| Total Assets | 3.14B | ||
| Debt Current | 6.51M | ||
| Total Debt | 115.45M | ||
| Current Liabilities | 271.28M | ||
| Debt Non-Current | 108.94M | ||
| Total Liabilities | 380.21M | ||
| Accumulated Retained Earnings (Deficit) | -2.76B | ||
| Accumulated Other Comprehensive Income | -7.55M | ||
| Shareholders Equity | 2.76B | ||
| Shareholders Equity (USD) | 2.76B | ||
| Assets Non-Current | 1.59B | ||
| Total Debt (USD) | 115.45M | ||
| Liabilities Non-Current | 108.94M | ||
| Trade and Non-Trade Payables | 100.92M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 5.93M | ||
| Net Cash Flow from Financing | 5.70M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -77.65M | ||
| Capital Expenditure | -4.57M | ||
| Issuance (Purchase) of Equity Shares | 7.76M | ||
| Net Cash Flow from Investing | 147.72M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 152.29M | ||
| Net Cash Flow from Operations | -232.47M | ||
| Effect of Exchange Rate Changes on Cash | 1.40M | ||
| Share Based Compensation | 41.24M | ||